GAMMA Investing’s Acrivon Therapeutics ACRV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
Sell
-287
Closed -$583 3774
2025
Q1
$583 Buy
287
+253
+744% +$514 ﹤0.01% 3653
2024
Q4
$205 Buy
+34
New +$205 ﹤0.01% 3702